Acral Melanoma

11 registered clinical trials studyying Acral Melanoma — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carbopla NCT07347444	Fudan University	Phase 2
Recruiting	Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metast NCT04119024	Anusha Kalbasi	Phase 1
Recruiting	Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial NCT06965231	Fudan University	Phase 2
Not Yet Recruiting	An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions. NCT06661577	University of Auckland, New Zealand	—
Recruiting	Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma NCT05789043	Peking University Cancer Hospital & Institute	Phase 3
Terminated	Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Pro NCT05436990	Yonsei University	Phase 2
Completed	Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma NCT05628883	H. Lee Moffitt Cancer Center and Research Institute	Phase 1
Recruiting	Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma NCT05512481	Peking University Cancer Hospital & Institute	Phase 2
Recruiting	A Beta-only IL-2 ImmunoTherapY Study NCT05086692	Medicenna Therapeutics, Inc.	Phase 1 / Phase 2
Recruiting	Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma NCT04331093	Di Wu	Phase 2
Completed	Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged M NCT00788775	Dana-Farber Cancer Institute	Phase 2